This program will review current and emerging immunotherapies for the management of patients with advanced NSCLC.

This program will explore the use of systemic therapies for the management of moderate-to-severe atopic dermatitis in pediatric and adult patients.

This program will review current and emerging therapies for the management of Severe Asthma.

This live virtual activity targets healthcare gaps related to the treatment and management of atrial fibrillation (AF), impacting outcomes through guidelines and best practices, appropriate antiarrhythmic use, and shared decision-making.

This program will explore the use of systemic therapies for the management of moderate-to-severe atopic dermatitis in pediatric and adult patients.

This activity will cover the assessment, monitoring, and treatment of Acute Myeloid Leukemia (AML).

This live virtual activity targets healthcare gaps related to the treatment and management of atrial fibrillation (AF), impacting outcomes through guidelines and best practices, appropriate antiarrhythmic use, and shared decision-making.

Fill out your Evaluation Form

The COVID-19 FRONTLINE Grand Rounds series provides a comprehensive and up-to-date perspective on the ever-changing management of patients with COVID-19. Each Grand Rounds session features in-depth case studies to encourage retention of the lessons and provide new perspectives on the management of patients during the COVID-19 pandemic. This program will focus on optimizing outcomes for hospitalized and nonhospitalized patients with COVID-19 through the use of novel agents authorized for emergency use.

The case-based virtual live activity will cover the treatment and management of patients with chronic and diabetic kidney disease.

The case-based virtual live activity will cover the treatment and management of patients with chronic and diabetic kidney disease.

This live virtual activity targets healthcare gaps related to the treatment and management of atrial fibrillation (AF), impacting outcomes through guidelines and best practices, appropriate antiarrhythmic use, and shared decision-making.